Eli Lilly Raises 2013 Guidance After Q2 Sales Rise

July 24 (Bloomberg) -- Eli Lilly & Co., the maker of the antidepressant Cymbalta and diabetes treatment Humalog, raised its full-year guidance after second-quarter sales grew faster than expected and cost-cutting programs took effect. Olivia Sterns reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

EFG Hermes' Hajj Sees Break in Dollar, Oil Relationship
20:13 - EFG Hermes MENA Equity Strategist Mohamad Al Hajj discusses his outlook for emerging markets and weighs in on President Trump's Middle East policy. He speaks on "Bloomberg Markets: Middle East." (Source: Bloomberg)
  • Why Middle East Airlines May See Tough Times Ahead
  • Full Show: Bloomberg Markets Middle East (04/30)
  • Full Show: Bloomberg Markets Middle East (04/27)